Natixis Advisors LLC Boosts Stake in Cigna Group (NYSE:CI)

Natixis Advisors LLC raised its holdings in Cigna Group (NYSE:CI) by 7.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 385,667 shares of the health services provider’s stock after acquiring an additional 27,716 shares during the period. Natixis Advisors LLC’s holdings in Cigna Group were worth $126,884,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. Level Four Advisory Services LLC raised its position in Cigna Group by 12.1% during the fourth quarter. Level Four Advisory Services LLC now owns 1,941 shares of the health services provider’s stock valued at $536,000 after purchasing an additional 210 shares in the last quarter. RWA Wealth Partners LLC lifted its stake in Cigna Group by 2.2% during the fourth quarter. RWA Wealth Partners LLC now owns 3,127 shares of the health services provider’s stock worth $863,000 after purchasing an additional 67 shares during the last quarter. Wellington Management Group LLP lifted its stake in Cigna Group by 11.1% during the fourth quarter. Wellington Management Group LLP now owns 16,869 shares of the health services provider’s stock worth $4,658,000 after purchasing an additional 1,689 shares during the last quarter. Finally, Summit Financial LLC boosted its holdings in shares of Cigna Group by 36.9% in the 4th quarter. Summit Financial LLC now owns 2,104 shares of the health services provider’s stock worth $581,000 after purchasing an additional 567 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

CI opened at $291.97 on Wednesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72. The stock has a market capitalization of $78.00 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The stock’s 50 day moving average price is $311.29 and its 200-day moving average price is $312.28. Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. During the same period in the previous year, the firm earned $6.47 EPS. The company’s quarterly revenue was up 14.4% compared to the same quarter last year. On average, equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date is Thursday, September 4th. Cigna Group’s payout ratio is currently 33.44%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CI. Piper Sandler raised their price objective on Cigna Group from $348.00 to $374.00 and gave the company an “overweight” rating in a report on Monday, May 5th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 price target on shares of Cigna Group in a research report on Thursday, June 26th. Morgan Stanley lifted their price target on shares of Cigna Group from $379.00 to $390.00 and gave the stock an “overweight” rating in a research note on Monday, May 5th. Barclays reaffirmed an “overweight” rating and issued a $385.00 price objective (up previously from $382.00) on shares of Cigna Group in a research note on Monday, June 2nd. Finally, Wall Street Zen lowered shares of Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Friday, July 18th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $380.39.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.